Now that April is nearly concluded, I will turn my attention to the dividend stock purchases that I executed during the month.
Dividend Stock Purchase #1: PepsiCo (PEP)
In alphabetical order, my first dividend stock purchase this month was an additional seven shares of PepsiCo (PEP) at an average cost of $168.47 a share. This was a $38.22 boost to my net annual forward dividends, which equates to a 3.24% net dividend yield.
As I noted in my April 2024 Dividend Stock Watch List blog post, interested readers can check out last September's Seeking Alpha article for my investment thesis.
Dividend Stock Purchase #2: Starbucks (SBUX)
My next dividend stock purchase for the month was 13 shares of Starbucks (SBUX) at an average price per share of $85.98. This purchase lifted my net annual forward dividends by $29.64, which works out to a 2.65% net yield.
Readers who want to learn more about my investment thesis for SBUX can check out the April 2024 Dividend Stock Watch List blog post that I linked to earlier.
Dividend Stock Purchase #3: UnitedHealth Group (UNH)
My final dividend stock purchase during April was two shares of UnitedHealth Group (UNH) at an average cost of $451.14 a share. This transaction increased my net annual forward dividends by $15.04, which is equivalent to a 1.67% net dividend yield.
For my investment thesis, readers can peruse my February Seeking Alpha article.
Concluding Thoughts:
I put $3,199.31 of capital to work in April. Against the $82.90 in net annual forward dividends, that is a 2.59% weighted average net dividend yield.
Combined with the $19.88 in dividend increases/initiated dividends for the month, my net annual forward dividends climbed from around $4,480 to approximately $4,580 to conclude April.
Discussion:
How was your capital deployment for April 2024?
Did you open any new positions?
I appreciate your readership and welcome your comments below!
I opened a new position in American Water Works (AWK) and Genpact Limited (G) in April 2024. Both look attractive at today's prices with high single digit growth prospects ahead. I increased my position in Whirlpool (WHR) and Bristol Myers Squibb (BMY). Both are in a recovery/transition phase. But, for now, their valuations look attractive with well above average dividend yields.
ReplyDeleteCongrats on the new positions and adds. With a 0.4% weighting in my position, AWK is a relatively small position in my portfolio. It's definitely on my radar to add more, though.
ReplyDelete